Literature DB >> 15365700

Determinants of changes in bone mass and femoral neck structure, and physical performance after menopause: a 9-year follow-up of initially peri-menopausal women.

Kirsti Uusi-Rasi1, Harri Sievänen, Ari Heinonen, Thomas J Beck, Ilkka Vuori.   

Abstract

This prospective study set out to determine factors that underlie changes in bone characteristics and physical performance during postmenopausal years. Of 101 peri-menopausal women that originally participated in a randomized, controlled exercise intervention trial, 80 attended the follow-up measurements 9 years later. At follow-up, bone mineral content (BMC) of the lumbar spine, femoral neck and distal radius, as well as the maximal isometric muscle strength of leg extensors and arm flexors, and maximal oxygen uptake, were measured with the same protocols and devices as at the baseline. In addition, the hip structure analysis (HSA) was used to assess changes in the structure and strength at the narrowest section of the femoral neck. Changes in physical fitness or bone characteristics were independent of the original exercise intervention. In general, physical fitness declined with age from 5% to 30% and bone characteristics from 3% to 10%, except for the lumbar spine BMC and the periosteal diameter of the femoral neck, where no changes were observed. The use of hormone therapy (HRT) was the major factor accounting for the maintenance of BMC. Use of HRT alone explained 44% of the variability in the change at the femoral neck BMC, but it was not associated with changes in physical fitness. Change in the body weight was the only factor associated with the change in physical fitness: better maintenance in body weight predicted better maintenance of physical fitness. In conclusion, our results indicate that HRT helps to maintain bone mass and structure, which are important factors in prevention of fragility fractures in later life. However, HRT had no effect on physical fitness, which is highly associated with the risk of falling, the most important cause of fractures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365700     DOI: 10.1007/s00198-004-1724-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Randomised, controlled walking trials in postmenopausal women: the minimum dose to improve aerobic fitness?

Authors:  T-M Asikainen; S Miilunpalo; P Oja; M Rinne; M Pasanen; K Uusi-Rasi; I Vuori
Journal:  Br J Sports Med       Date:  2002-06       Impact factor: 13.800

2.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group.

Authors:  J A Grisso; J L Kelsey; B L Strom; G Y Chiu; G Maislin; L A O'Brien; S Hoffman; F Kaplan
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

3.  Bone dimensional change with age: interactions of genetic, hormonal, and body size variables.

Authors:  R P Heaney; M J Barger-Lux; K M Davies; R A Ryan; M L Johnson; G Gong
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

Authors: 
Journal:  JAMA       Date:  1996-11-06       Impact factor: 56.272

5.  Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures.

Authors:  T J Beck; K L Stone; T L Oreskovic; M C Hochberg; M C Nevitt; H K Genant; S R Cummings
Journal:  J Bone Miner Res       Date:  2001-11       Impact factor: 6.741

6.  Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients.

Authors:  J Parkkari; P Kannus; M Palvanen; A Natri; J Vainio; H Aho; I Vuori; M Järvinen
Journal:  Calcif Tissue Int       Date:  1999-09       Impact factor: 4.333

7.  Hormone replacement therapy does not augment gains in muscle strength or fat-free mass in response to weight-bearing exercise.

Authors:  M Brown; S J Birge; W M Kohrt
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-05       Impact factor: 6.053

8.  HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women.

Authors:  J Heikkinen; E Kyllönen; E Kurttila-Matero; G Wilén-Rosenqvist; K S Lankinen; H Rita; H K Väänänen
Journal:  Maturitas       Date:  1997-03       Impact factor: 4.342

9.  Bone loss and bone size after menopause.

Authors:  Henrik G Ahlborg; Olof Johnell; Charles H Turner; Gunnar Rannevik; Magnus K Karlsson
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

10.  Maximal muscle strength of elderly women is not influenced by oestrogen status.

Authors:  D R Taaffe; M Luz Villa; R Delay; R Marcus
Journal:  Age Ageing       Date:  1995-07       Impact factor: 10.668

View more
  6 in total

1.  Long-term recreational gymnastics provides a clear benefit in age-related functional decline and bone loss. A prospective 6-year study.

Authors:  K Uusi-Rasi; H Sievänen; A Heinonen; I Vuori; T J Beck; P Kannus
Journal:  Osteoporos Int       Date:  2006-06-07       Impact factor: 4.507

2.  Inter-sex differences in structural properties of aging femora: implications on differential bone fragility: a cadaver study.

Authors:  Danijela Djonic; Petar Milovanovic; Slobodan Nikolic; Miomira Ivovic; Jelena Marinkovic; Thomas Beck; Marija Djuric
Journal:  J Bone Miner Metab       Date:  2010-12-04       Impact factor: 2.626

Review 3.  The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  S Soltani; G R Hunter; A Kazemi; S Shab-Bidar
Journal:  Osteoporos Int       Date:  2016-05-06       Impact factor: 4.507

4.  Hip structural geometry in old and old-old age: similarities and differences between men and women.

Authors:  Laurel B Yates; David Karasik; Thomas J Beck; L Adrienne Cupples; Douglas P Kiel
Journal:  Bone       Date:  2007-06-15       Impact factor: 4.398

5.  Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women.

Authors:  G J van Londen; S Perera; K T Vujevich; S M Sereika; R Bhattacharya; S L Greenspan
Journal:  Bone       Date:  2008-04-15       Impact factor: 4.398

6.  Genetics of the musculoskeletal system: a pleiotropic approach.

Authors:  David Karasik; Douglas P Kiel
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.